Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen

MT Newswires Live2024-09-13

Nihon Kohden (TYO:6849) is acquiring a majority stake of 71.4% in NeuroAdvanced, the parent company of Ad-Tech Medical Instrument, for about 16 billion yen.

As a result, the medical equipment manufacturer said Ad-Tech will become consolidated and specified subsidiaries of Nihon Kohden, according to its filing on Thursday.

The acquisition involves a stock purchase agreement with NeuroNewCo, a fund which owns 100% shares in NeuroAdvanced, and a shareholders agreement outlining future business operations and potential full acquisition of NeuroAdvanced.

The acquisition is part of Nihon Kohden's long-term vision to solve global medical issues and expand its consumables and services business in North America.

The share transfer is scheduled to take place Nov. 29

Nihon Kohden's shares gained over 2% in early trade.

Price (JPY): $2089.00, Change: $+45, Percent Change: +2.18%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467555765?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-13 09:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467555765","market":"us","top_or_hot":-1,"title":"Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen","media":"MT Newswires Live","content":"<html><body><p>Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen</p><p> Nihon Kohden (TYO:6849) is acquiring a majority stake of 71.4% in NeuroAdvanced, the parent company of Ad-Tech Medical Instrument, for about 16 billion yen.</p><p>As a result, the medical equipment manufacturer said Ad-Tech will become consolidated and specified subsidiaries of Nihon Kohden, according to its filing on Thursday.</p><p>The acquisition involves a stock purchase agreement with NeuroNewCo, a fund which owns 100% shares in NeuroAdvanced, and a shareholders agreement outlining future business operations and potential full acquisition of  NeuroAdvanced.</p><p>The acquisition is part of Nihon Kohden's long-term vision to solve global medical issues and expand its consumables and services business in North America.</p><p>The share transfer is scheduled to take place Nov. 29</p><p>Nihon Kohden's shares gained over 2% in early trade.</p><p>Price (JPY): $2089.00, Change: $+45, Percent Change: +2.18%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-13 09:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen Nihon Kohden (TYO:6849) is acquiring a majority stake of 71.4% in NeuroAdvanced, the parent company of Ad-Tech Medical ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TYO","symbol_name":"3倍做空7-10年期国债ETF-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2467555765","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467555765","pubTimestamp":1726191999,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen Nihon Kohden (TYO:6849) i","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TYO":"3倍做空7-10年期国债ETF-Direxion"},"translate_title":"日本光电将以160亿日元收购NeuroAdvanced多数股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TYO":1},"content_text":"Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen Nihon Kohden (TYO:6849) is acquiring a majority stake of 71.4% in NeuroAdvanced, the parent company of Ad-Tech Medical Instrument, for about 16 billion yen.As a result, the medical equipment manufacturer said Ad-Tech will become consolidated and specified subsidiaries of Nihon Kohden, according to its filing on Thursday.The acquisition involves a stock purchase agreement with NeuroNewCo, a fund which owns 100% shares in NeuroAdvanced, and a shareholders agreement outlining future business operations and potential full acquisition of  NeuroAdvanced.The acquisition is part of Nihon Kohden's long-term vision to solve global medical issues and expand its consumables and services business in North America.The share transfer is scheduled to take place Nov. 29Nihon Kohden's shares gained over 2% in early trade.Price (JPY): $2089.00, Change: $+45, Percent Change: +2.18%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467555765","isCrawlerRequest":true}